性别对儿科急诊室临床决策的影响 头痛 访问 性别对临床决定的影响
Lea Ohana Sarna Cahan1, Miriam Ben-Hamo2, Jehad Edrees1
1Department of Pediatric Emergency Medicine, Hadassah. Hebrew University Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
The American journal of emergency medicine
|September 24, 2025
概括
患有头痛的女性青少年更有可能去看专家,而女性提供者使用更多的资源,并且回访患者的次数更少. 这些发现表明,儿童紧急护理决策中的性别影响.
科学领域:
- 儿科急救医学 儿科急救医学
- 医疗保健服务研究 医疗服务研究
- 在医疗保健中的性别研究.
背景情况:
- 关于儿科紧急护理中的性别和性别差异的数据有限.
- 这项研究的重点是青少年向儿科急诊部 (PED) 提出头痛的情况.
研究的目的:
- 评估患者表现和青少年头痛诊断的性别相关差异.
- 检查PED中与医疗保健提供者管理有关的性别影响.
主要方法:
- 追溯观察队列审查10-17岁患者出现头痛 (2010-2022年).
- 收集的数据包括人口统计,诊断,测试,咨询,住院,再入院,出院时间和入院医生的性别.
主要成果:
- 女性患者更有可能被转诊给子专家,特别是眼科医生 (p=0.042).
- 女患者更有可能被指导到专家 (p=0.009),无论提供者的性别.
- 女性提供者更有可能订购血液化学测试 (p=0.042) 和精神科咨询 (p=0.002),导致更长的PED停留.
- 在男性提供者治疗的男性患者中,与女性提供者治疗的男性患者相比,复诊的几率更高 (OR 2.00).
结论:
- 在评估青少年头痛时,观察到与性别相关的轻微差异.
- 女性医疗保健提供者利用了更多的PED资源,并进行了更长的评估,与更少的再访相关.
- 调查结果表明,与性别相关的潜在影响在儿科紧急护理中对提供者决策产生影响.
更多相关视频
10:393D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.7K
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
16.6K
相关概念视频
01:30Socioemotional Experience and Gender Development
266
Social-emotional experiences and cultural influences play significant roles in shaping gender development. During middle childhood, from ages 6 to 11, peer groups become dominant in reinforcing gender norms. Children in this age group often align with same-gender peer groups, which actively encourage behaviors that conform to traditional gender roles. For instance, boys may be discouraged from engaging in activities perceived as feminine, reinforcing culturally dictated norms about masculinity...
266
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
254
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
01:29Drug Dosing: Infants and Children
255
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
255
01:27Panic Disorder
637
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
637
01:21Factors Affecting Drug Response: Overview
3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
193
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
193